Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Dougherty

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Human Mutation|December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practiceGillian Ellison, Miika Ahdesmäki, Sally Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian CarcinomaAilith Ewing, Alison Meynert, Michael Churchman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.
Environmental Science. Processes & Impacts|July 2, 2024
The chemical assessment of surfaces and air (CASA) study: using chemical and physical perturbations in a test house to investigate indoor processesDelphine K Farmer, Marina E Vance, Dustin Poppendieck, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|July 2, 2025
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancerAilith Ewing, Alison Meynert, Ryan Silk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
AKT Inhibition in Solid Tumors With AKT1 MutationsDavid M Hyman, Lillian M Smyth, Mark T A Donoghue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Human Mutation|December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practiceGillian Ellison, Miika Ahdesmäki, Sally Luke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 20, 2021
Structural Variants at the <i>BRCA1/2</i> Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian CarcinomaAilith Ewing, Alison Meynert, Michael Churchman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.
Environmental Science. Processes & Impacts|July 2, 2024
The chemical assessment of surfaces and air (CASA) study: using chemical and physical perturbations in a test house to investigate indoor processesDelphine K Farmer, Marina E Vance, Dustin Poppendieck, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2024
Characterising the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|February 19, 2025
Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 casesJonathan Mitchell, Niedzica Camacho, Patrick Shea, et al.
Nature Communications|July 2, 2025
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancerAilith Ewing, Alison Meynert, Ryan Silk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2017
AKT Inhibition in Solid Tumors With AKT1 MutationsDavid M Hyman, Lillian M Smyth, Mark T A Donoghue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor ResistanceVioleta Serra, Anderson T Wang, Marta Castroviejo-Bermejo, et al.
Pageof 4